Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 70518-4446

4 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70518-4446). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8d9e24d7 369e 43b6 83be Babf9d9cf3e3 01)

FDA Label Image

Image (5e0af71c Ee29 4550 84d5 Fde1e1352d47 1475 1)

FDA Label Image

Image (5e0af71c Ee29 4550 84d5 Fde1e1352d47 1516 1)

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Bupropion Hydrochloride 300 mg extended-release tablets, containing 30 tablets per package. The tablets are round and white, identified as L016. The product is repackaged by RemedyRepack Inc. in Indiana, with manufacturing by Lupin Pharma in Baltimore, MD. Includes storage instructions and a note to keep medication out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.